1173 - Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

Page last updated: 13 July 2016

Application Detail

Status

Closed

Description of Medical Service

-

Description of Medical Condition

-

Reason for Application

-

Medical Service Type

-

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Consultation Decision Analytic Protocol (PDF 372 KB)
Consultation Decision Analytic Protocol (Word 932 KB)

Final Decision Analytic Protocol (PDF 412 KB)
Final Decision Analytic Protocol (Word 818 KB)

Assessment Report

-

Public Summary Document

Public Summary Document - August 2012 (PDF 116 KB)
Public Summary Document - August 2012 (Word 691 KB)

Public Summary Document - August 2013 (PDF 136 KB)
Public Summary Document - August 2013 (Word 103 KB)

Meetings for this Application

PASC

14 - 15 September 2011
1 - 2 December 2011

ESC

-

MSAC

2 August 2012
1 August 2013